{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:10Z","timestamp":1772165770087,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Taejoon Pharm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12886-019-1136-8","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T09:07:11Z","timestamp":1560762431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Chang Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Keun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mee Kum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-im","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Kyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Suk","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-8612","authenticated-orcid":false,"given":"Hyun Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"3","key":"1136_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365.","journal-title":"Ocul Surf"},{"key":"1136_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","volume":"182","author":"KF Farrand","year":"2017","unstructured":"Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"1136_CR3","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1136\/bjophthalmol-2014-305201","volume":"98","author":"J Vehof","year":"2014","unstructured":"Vehof J, Kozareva D, Hysi PG, Hammond CJ. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1136_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"3","key":"1136_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438\u2013510.","journal-title":"Ocul Surf"},{"issue":"3","key":"1136_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"10","key":"1136_CR7","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/bjo.2008.150011","volume":"94","author":"L Baiza-Duran","year":"2010","unstructured":"Baiza-Duran L, Medrano-Palafox J, Hernandez-Quintela E, Lozano-Alcazar J, Alaniz-de la OJ. A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome. Br J Ophthalmol. 2010;94(10):1312\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1136_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/jop.2009.0145","volume":"26","author":"M Chen","year":"2010","unstructured":"Chen M, Gong L, Sun X, Xie H, Zhang Y, Zou L, Qu J, Li Y, He J. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial. J Ocul Pharmacol Ther. 2010;26(4):361\u20136.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"10","key":"1136_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1136\/bjophthalmol-2011-301448","volume":"96","author":"E Takamura","year":"2012","unstructured":"Takamura E, Tsubota K, Watanabe H, Ohashi Y. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol. 2012;96(10):1310\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"1136_CR10","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","volume":"119","author":"Y Matsumoto","year":"2012","unstructured":"Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Ophthalmology. 2012;119(10):1954\u201360.","journal-title":"Ophthalmology"},{"key":"1136_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ajo.2015.12.002","volume":"163","author":"DH Park","year":"2016","unstructured":"Park DH, Chung JK, Seo DR, Lee SJ. Clinical effects and safety of 3% Diquafosol ophthalmic solution for patients with dry eye after cataract surgery: a randomized controlled trial. Am J Ophthalmol. 2016;163:122\u201331 e122.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1136_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2012-302668","volume":"97","author":"R Arita","year":"2013","unstructured":"Arita R, Suehiro J, Haraguchi T, Maeda S, Maeda K, Tokoro H, Amano S. Topical diquafosol for patients with obstructive meibomian gland dysfunction. Br J Ophthalmol. 2013;97(6):725\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1136_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/eye.2016.54","volume":"30","author":"N Yokoi","year":"2016","unstructured":"Yokoi N, Kato H, Kinoshita S. The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjogren\u2019s syndrome: a pilot study. Eye (London, England). 2016;30(6):857\u201364.","journal-title":"Eye (London, England)"},{"key":"1136_CR14","first-page":"8150757","volume":"2016","author":"JH Lee","year":"2016","unstructured":"Lee JH, Song IS, Kim KL, Yoon SY. Effectiveness and optical quality of topical 3.0% Diquafosol versus 0.05% cyclosporine a in dry eye patients following cataract surgery. J Ophthalmol. 2016;2016:8150757.","journal-title":"J Ophthalmol"},{"issue":"9","key":"1136_CR15","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1097\/OPX.0000000000000657","volume":"92","author":"JM Yang","year":"2015","unstructured":"Yang JM, Choi W, Kim N, Yoon KC. Comparison of topical cyclosporine and Diquafosol treatment in dry eye. Optom Vis Sci. 2015;92(9):e296\u2013302.","journal-title":"Optom Vis Sci"},{"issue":"4","key":"1136_CR16","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA. Report of the National eye Institute\/industry workshop on clinical trials in dry eyes. CLAO J. 1995;21(4):221\u201332.","journal-title":"CLAO J"},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajo.2017.05.022","volume":"180","author":"N Yokoi","year":"2017","unstructured":"Yokoi N, Georgiev GA, Kato H, Komuro A, Sonomura Y, Sotozono C, Tsubota K, Kinoshita S. Classification of fluorescein breakup patterns: a novel method of differential diagnosis for dry eye. Am J Ophthalmol. 2017;180:72\u201385.","journal-title":"Am J Ophthalmol"},{"issue":"11s","key":"1136_CR18","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology. 2017;124(11s):S4\u2013s13.","journal-title":"Ophthalmology"},{"issue":"1","key":"1136_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OPTH.S1496","volume":"2","author":"G Savini","year":"2008","unstructured":"Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol (Auckland, NZ). 2008;2(1):31\u201355.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"1","key":"1136_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","volume":"130","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Chauhan SK, Dana R. Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol (Chicago, Ill : 1960). 2012;130(1):90\u2013100.","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"issue":"2","key":"1136_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2005.09.033","volume":"113","author":"HK Lee","year":"2006","unstructured":"Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Ophthalmology. 2006;113(2):198\u2013205.","journal-title":"Ophthalmology"},{"issue":"7","key":"1136_CR22","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1097\/MD.0000000000000551","volume":"94","author":"T Lin","year":"2015","unstructured":"Lin T, Gong L. Topical fluorometholone treatment for ocular dryness in patients with Sjogren syndrome: a randomized clinical trial in China. Medicine. 2015;94(7):e551.","journal-title":"Medicine"},{"issue":"4","key":"1136_CR23","first-page":"593","volume":"11","author":"HY Kim","year":"2018","unstructured":"Kim HY, Lee JE, Oh HN, Song JW, Han SY, Lee JS. Clinical efficacy of combined topical 0.05% cyclosporine a and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction. Int J Ophthalmol. 2018;11(4):593\u2013600.","journal-title":"Int J Ophthalmol"},{"issue":"9","key":"1136_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/ICO.0000000000000213","volume":"33","author":"HS Hwang","year":"2014","unstructured":"Hwang HS, Sung YM, Lee WS, Kim EC. Additive effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops. Cornea. 2014;33(9):935\u201341.","journal-title":"Cornea"},{"issue":"1","key":"1136_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2478\/s11658-008-0041-6","volume":"14","author":"A Czogalla","year":"2009","unstructured":"Czogalla A. Oral cyclosporine A--the current picture of its liposomal and other delivery systems. Cell Mol Biol Lett. 2009;14(1):139\u201352.","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"1136_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","volume":"56","author":"F Lallemand","year":"2003","unstructured":"Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. Cyclosporine a delivery to the eye: a pharmaceutical challenge. Eur J Pharm Biopharm. 2003;56(3):307\u201318.","journal-title":"Eur J Pharm Biopharm."},{"issue":"1","key":"1136_CR27","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1208\/pt020102","volume":"2","author":"Y Ran","year":"2001","unstructured":"Ran Y, Zhao L, Xu Q, Yalkowsky SH. Solubilization of cyclosporin A. AAPS PharmSciTech. 2001;2(1):E2.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1136_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cocis.2015.07.005","volume":"20","author":"P Gruner","year":"2015","unstructured":"Gruner P, Riechers B, Chac\u00f2n Orellana LA, Brosseau Q, Maes F, Beneyton T, Pekin D, Baret J-C. Stabilisers for water-in-fluorinated-oil dispersions: key properties for microfluidic applications. Curr Opin Colloid Interface Sci. 2015;20(3):183\u201391.","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"1136_CR29","first-page":"15","volume":"4","author":"A Thakur","year":"2013","unstructured":"Thakur A, Walia MK, Kumar SL. Nanoemulsion in enhancement of bioavailability of poorly soluble drugs: a review. Pharmacophore. 2013;4:15\u201325.","journal-title":"Pharmacophore"},{"issue":"4","key":"1136_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2478\/acph-2013-0040","volume":"63","author":"K Cerpnjak","year":"2013","unstructured":"Cerpnjak K, Zvonar A, Gasperlin M, Vrecer F. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63(4):427\u201345.","journal-title":"Acta Pharm"},{"issue":"8","key":"1136_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","volume":"126","author":"HD Perry","year":"2008","unstructured":"Perry HD, Solomon R, Donnenfeld ED, Perry AR, Wittpenn JR, Greenman HE, Savage HE. Evaluation of topical cyclosporine for the treatment of dry eye disease. Arch Ophthalmol. 2008;126(8):1046\u201350.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"1136_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","volume":"32","author":"GM Salib","year":"2006","unstructured":"Salib GM, McDonald MB, Smolek M. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. J Cataract Refract Surg. 2006;32(5):772\u20138.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"1136_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, Benitez-Del-Castillo JM, Dana R, Deng SX, Dong PN, Geerling G, Hida RY, Liu Y, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628.","journal-title":"Ocul Surf"}],"updated-by":[{"DOI":"10.1186\/s12886-020-01524-8","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"record-id":"23627"},{"DOI":"10.1186\/s12886-020-01524-8","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000}}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1136-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1136-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T02:04:14Z","timestamp":1593482654000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1136-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1136-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.487\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.487\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.487\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.487\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the ethical principles specified in the Declaration of Helsinki and Good Clinical Practice Guidelines. This study was approved by the institutional review board (IRB) in each center: Institutional Review Board of Yeouido St. Mary\u2019s Hospital, Gangnam Severance Hospital, Seoul National University Hospital, Bucheon St. Mary\u2019s Hospital, Seoul Asan Medical Center, Severance Hospital, Kyungpook National University Hospital, Korea University Guro Hospital, Chonnam National University Hospital, Ilsan Paik Hospital, Samsung Medical Center and Kangbuk Samsung Hospital. Additionally, this trial was registered on the Current Research Information System (CRIS) (\n                      \n                      ) and World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP,\n                      \n                      ). The trial registration number is KCT0002180. Written informed consent was obtained from each patient prior to participation in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}